Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Non-Current Assets (2016 - 2025)

Apyx Medical (APYX) has disclosed Other Non-Current Assets for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 5.29% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2025, up 5.29%, and an annual FY2025 reading of $1.8 million, up 5.29% over the prior year.
  • Other Non-Current Assets was $1.8 million for Q4 2025 at Apyx Medical, down from $1.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.9 million in Q2 2023 and bottomed at $860000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $1.5 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets skyrocketed 107.68% in 2021, then fell 6.39% in 2025.
  • Year by year, Other Non-Current Assets stood at $1.1 million in 2021, then grew by 9.64% to $1.2 million in 2022, then surged by 42.32% to $1.7 million in 2023, then dropped by 3.93% to $1.7 million in 2024, then increased by 5.29% to $1.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for APYX at $1.8 million in Q4 2025, $1.8 million in Q3 2025, and $1.7 million in Q2 2025.